Skip to main content
Top

Familial Cancer

Issue 2/2007

Delivering Cancer Genetics Services - New Ways of Working

Content (14 Articles)

Foreword

Foreword

Mike Richards

Delivering cancer genetics services-new ways of working

Ros Eeles, Glyn Purland, Jane Maher, D. Gareth Evans

Open letter

Open letter

Providing a community-based cancer risk assessment service for a socially and ethnically diverse population

C. Jacobs, R. Rawson, C. Campion, C. Caulfield, J. Heath, C. Burton, F. Kavalier

Nurse-led cancer genetics clinics in primary and secondary care in varied ethnic population areas: interaction with primary care to improve ascertainment of individuals from ethnic minorities

Zohra Gulzar, Sheila Goff, Albert Njindou, Heather Hearty, Imran Rafi, Rosie Savage, Gaya Matta, Julie Ferras, Shirley Hodgson

Delivery of cancer genetics services: The Royal Marsden telephone clinic model

S. Shanley, K. Myhill, R. Doherty, A. Ardern-Jones, S. Hall, C. Vince, S. Thomas, P. Aspinall, R. Eeles

Patient perspectives on the Poole PCT cancer genetics service

Helen Allen, Lynn Maxwell, Nikki Dibley, Angela Bradley, Roger Baker, Peter Thomas, Donna McBride

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine